Two Sigma Advisers’s Antares Pharma, Inc. ATRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-574,732
| Closed | -$2.36M | – | 2989 |
|
|
2022
Q1 | $2.36M | Sell |
574,732
-91,800
| -14% | -$376K | 0.01% | 1164 |
|
|
2021
Q4 | $2.38M | Sell |
666,532
-503,800
| -43% | -$1.8M | 0.01% | 1106 |
|
|
2021
Q3 | $4.26M | Sell |
1,170,332
-140,900
| -11% | -$513K | 0.01% | 866 |
|
|
2021
Q2 | $5.72M | Buy |
1,311,232
+126,800
| +11% | +$553K | 0.02% | 800 |
|
|
2021
Q1 | $4.87M | Sell |
1,184,432
-40,200
| -3% | -$165K | 0.01% | 864 |
|
|
2020
Q4 | $4.89M | Sell |
1,224,632
-105,600
| -8% | -$421K | 0.01% | 830 |
|
|
2020
Q3 | $3.59M | Sell |
1,330,232
-323,300
| -20% | -$873K | 0.01% | 885 |
|
|
2020
Q2 | $4.55M | Buy |
1,653,532
+86,700
| +6% | +$238K | 0.01% | 837 |
|
|
2020
Q1 | $3.7M | Buy |
1,566,832
+178,900
| +13% | +$422K | 0.01% | 831 |
|
|
2019
Q4 | $6.52M | Buy |
1,387,932
+942,600
| +212% | +$4.43M | 0.02% | 736 |
|
|
2019
Q3 | $1.49M | Buy |
445,332
+3,800
| +0.9% | +$12.7K | ﹤0.01% | 1245 |
|
|
2019
Q2 | $1.45M | Buy |
441,532
+49,000
| +12% | +$161K | ﹤0.01% | 1345 |
|
|
2019
Q1 | $1.19M | Buy |
392,532
+68,900
| +21% | +$209K | ﹤0.01% | 1443 |
|
|
2018
Q4 | $880K | Buy |
323,632
+208,100
| +180% | +$566K | ﹤0.01% | 1542 |
|
|
2018
Q3 | $388K | Buy |
+115,532
| New | +$388K | ﹤0.01% | 1885 |
|
|
2018
Q2 | – | Sell |
-21,332
| Closed | -$47K | – | 2543 |
|
|
2018
Q1 | $47K | Sell |
21,332
-38,987
| -65% | -$85.9K | ﹤0.01% | 2257 |
|
|
2017
Q4 | $120K | Buy |
60,319
+4,134
| +7% | +$8.22K | ﹤0.01% | 2137 |
|
|
2017
Q3 | $182K | Buy |
56,185
+36,085
| +180% | +$117K | ﹤0.01% | 2071 |
|
|
2017
Q2 | $65K | Buy |
+20,100
| New | +$65K | ﹤0.01% | 2195 |
|
|
2016
Q3 | – | Sell |
-20,300
| Closed | -$21K | – | 2348 |
|
|
2016
Q2 | $21K | Buy |
20,300
+100
| +0.5% | +$103 | ﹤0.01% | 2024 |
|
|
2016
Q1 | $18K | Buy |
+20,200
| New | +$18K | ﹤0.01% | 2006 |
|